Trial Profile
A prospective study to assess emergence and transmissibility of drug resistance to neuraminidase inhibitor following treatment of children and adults with acute pandemic influenza
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 09 Oct 2013
Price :
$35
*
At a glance
- Drugs Oseltamivir (Primary) ; Zanamivir (Primary)
- Indications Influenza A virus H1N1 subtype
- Focus Pharmacodynamics; Pharmacogenomic
- 21 Jun 2012 Actual end date (31 Mar 2011) added as reported by European Clinical Trials Database.
- 16 Jun 2011 New trial record